Literature DB >> 30713913

Improvement in Ephedrone Parkinsonism After Global Pallidus Pars Interna Deep Brain Stimulation Implantation.

Dariusz Koziorowski1, Stanislaw Szlufik1, Tomasz Mandat2,3, Maria Kloda1, Karolina Duszynska-Was1, Agnieszka Drzewinska1, Andrzej Friedman1.   

Abstract

Entities:  

Keywords:  GPi DBS; ephedrone parkinsonism

Year:  2015        PMID： 30713913      PMCID： PMC6353412          DOI： 10.1002/mdc3.12248

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  10 in total

1.  ["Ephedron" encephalopathy].

Authors:  O S Levin
Journal:  Zh Nevrol Psikhiatr Im S S Korsakova       Date:  2005

2.  Pallidal stimulation for acquired dystonia due to cerebral palsy: beyond 5 years.

Authors:  L M Romito; G Zorzi; C E Marras; A Franzini; N Nardocci; A Albanese
Journal:  Eur J Neurol       Date:  2014-11-10       Impact factor: 6.089

3.  Bilateral pallidal deep brain stimulation for X-linked dystonia-parkinsonism.

Authors:  Akash J Patel; Aliya I Sarwar; Joseph Jankovic; Ashwin Viswanathan
Journal:  World Neurosurg       Date:  2013-09-25       Impact factor: 2.104

4.  Parkinsonism and dystonia caused by the illicit use of ephedrone--a longitudinal study.

Authors:  Marianna Selikhova; Ljuda Fedoryshyn; Yuri Matviyenko; Irena Komnatska; Marianna Kyrylchuk; Lesrek Krolicki; Andrzej Friedman; Andrew Taylor; H Rolf Jäger; Andrew Lees; Yanush Sanotsky
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

5.  The outcome of the movement disorder in methcathinone abusers: clinical, MRI and manganesemia changes, and neuropathology.

Authors:  A Stepens; V Groma; S Skuja; A Platkājis; P Aldiņš; I Ekšteina; I Mārtiņsone; R Bricis; M Donaghy
Journal:  Eur J Neurol       Date:  2013-05-17       Impact factor: 6.089

6.  Manganic encephalopathy due to "ephedrone" abuse.

Authors:  Yanush Sanotsky; Roman Lesyk; Lyudmyla Fedoryshyn; Iryna Komnatska; Yuriy Matviyenko; Stanley Fahn
Journal:  Mov Disord       Date:  2007-07-15       Impact factor: 10.338

7.  Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial.

Authors:  Jens Volkmann; Alexander Wolters; Andreas Kupsch; Jörg Müller; Andrea A Kühn; Gerd-Helge Schneider; Werner Poewe; Sascha Hering; Wilhelm Eisner; Jan-Uwe Müller; Günther Deuschl; Marcus O Pinsker; Inger-Marie Skogseid; Geir Ketil Roeste; Martin Krause; Volker Tronnier; Alfons Schnitzler; Jürgen Voges; Guido Nikkhah; Jan Vesper; Joseph Classen; Markus Naumann; Reiner Benecke
Journal:  Lancet Neurol       Date:  2012-11-01       Impact factor: 44.182

8.  A Parkinsonian syndrome in methcathinone users and the role of manganese.

Authors:  Ainārs Stepens; Ināra Logina; Viesturs Liguts; Pauls Aldins; Ilze Eksteina; Ardis Platkājis; Inese Mārtinsone; Elmārs Tērauds; Baiba Rozentāle; Michael Donaghy
Journal:  N Engl J Med       Date:  2008-03-06       Impact factor: 91.245

9.  Pallidal stimulation for primary generalised dystonia: effect on cognition, mood and quality of life.

Authors:  Marjan Jahanshahi; Mariam Torkamani; Mazda Beigi; Leonora Wilkinson; Donna Page; Laura Madeley; Kailash Bhatia; Marwan Hariz; Ludvic Zrinzo; Patricia Limousin; Diane Ruge; Stephen Tisch
Journal:  J Neurol       Date:  2013-11-01       Impact factor: 4.849

10.  Eye movements in ephedrone-induced parkinsonism.

Authors:  Cecilia Bonnet; Jan Rusz; Marika Megrelishvili; Tomáš Sieger; Olga Matoušková; Michael Okujava; Hana Brožová; Tomáš Nikolai; Jaromír Hanuška; Mariam Kapianidze; Nina Mikeladze; Nazi Botchorishvili; Irine Khatiashvili; Marina Janelidze; Tereza Serranová; Ondřej Fiala; Jan Roth; Jonas Bergquist; Robert Jech; Sophie Rivaud-Péchoux; Bertrand Gaymard; Evžen Růžička
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.